Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Maternal nanoplastic exposure left newborn mice with fewer ovarian follicles

16

Nov 2026

Maternal nanoplastic exposure left newborn mice with fewer ovarian follicles

Researchers found that maternal exposure to polystyrene nanoplastics disrupted early ovarian development in female mouse offspring, reducing primordial follicle numbers by approximately 22%. The findings linked impaired follicle formation to altered adhesion between immature egg cells, reduced granulosa cell proliferation, and increased apoptosis, although the long-term effects on fertility and relevance to humans remain uncertain.

Breast milk isn’t the same everywhere: What scientists found in nine countries

16

Nov 2026

Breast milk isn’t the same everywhere: What scientists found in nine countries

Researchers analyzed mature breast milk samples from 305 mothers across nine European and Asian countries to establish reference values for nutrients, fatty acids, and gangliosides among healthy, normally growing infants. The findings showed substantial geographical variation in several milk lipids, although small national samples and differences between populations limited the generalizability of the results.

Breast milk isn’t the same everywhere: What scientists found in nine countries

16

Nov 2026

Breast milk isn’t the same everywhere: What scientists found in nine countries

Researchers analyzed mature breast milk samples from 305 mothers across nine European and Asian countries to establish reference values for nutrients, fatty acids, and gangliosides among healthy, normally growing infants. The findings showed substantial geographical variation in several milk lipids, although small national samples and differences between populations limited the generalizability of the results.

Breast milk isn’t the same everywhere: What scientists found in nine countries

16

Nov 2026

Breast milk isn’t the same everywhere: What scientists found in nine countries

Researchers analyzed mature breast milk samples from 305 mothers across nine European and Asian countries to establish reference values for nutrients, fatty acids, and gangliosides among healthy, normally growing infants. The findings showed substantial geographical variation in several milk lipids, although small national samples and differences between populations limited the generalizability of the results.

AASM survey reveals how travel disrupts adult sleep patterns

16

Nov 2026

AASM survey reveals how travel disrupts adult sleep patterns

Whether traveling for business or pleasure, a good night's sleep isn't always part of the itinerary. According to a survey from the American Academy of Sleep Medicine, about one in four adults say they sleep slightly or significantly worse when traveling, whether for business (23%) or leisure (25%).

New NIH grant expands rare disease research in Michigan

16

Nov 2026

New NIH grant expands rare disease research in Michigan

A new $7.6 million grant from the National Institutes of Health, or NIH, will expand rare disease research and clinical care rooted in the story of Marley Berthoud, a Michigan child whose diagnosis helped scientists identify Bachmann-Bupp Syndrome and discover a new treatment.

Mobility data accurately predicts early spread of Congolese virus outbreak

16

Nov 2026

Mobility data accurately predicts early spread of Congolese virus outbreak

In the most detailed epidemiological assessment of the initial spread of Bundibugyo virus disease (BVD) in 2026 in the Democratic Republic of the Congo, scientists show that human movement - not geography or population size - was the principal driver of the virus's rapid early expansion across Ituri and neighbouring provinces.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.